Award amount Revenue From Grants, Maximum Award Revenue From Grants, Maximum Award Statistical Measurement [Domain] Statistical Measurement [Domain] Total current assets Assets, Current Research and development Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Stock options, contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Award Type [Domain] Award Type [Domain] Entity Filer Category Entity Filer Category Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Loss Per Share Earnings Per Share, Policy [Policy Text Block] Accounts payable Accounts Payable, Current Exercisable, weighted-average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Warrants outstanding (in shares) Class of Warrant or Right, Outstanding Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Commitments and contingencies (Note 5) Commitments and Contingencies Issued, weighted average grant date fair value (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Prepaid insurance Prepaid Insurance Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Proceeds from issuance or sale of equity Proceeds from Issuance or Sale of Equity STOCKHOLDERS' EQUITY Equity [Text Block] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Exercisable, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Ownership [Axis] Ownership [Axis] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Depreciation and amortization Depreciation, Depletion and Amortization Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Grants Receivable and Revenue Revenue [Policy Text Block] Current liabilities: Liabilities, Current [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Purchase in-process research and development technology Purchase in-process research and development technology Payments to Acquire in Process Research and Development Preferred stock, par value (in dollar per share) Preferred Stock, Par or Stated Value Per Share Total stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Preferred stock, $0.0001 par value; 10,000,000 shares authorized; 0 issued and outstanding Preferred Stock, Value, Issued Subsequent Event Type [Domain] Subsequent Event Type [Domain] Warrants exercised for cash, net (in shares) Stock Issued During Period, Shares, Warrants Exercised Stock Issued During Period, Shares, Warrants Exercised Impairment charges of long-lived assets Impairment, Long-Lived Asset, Held-for-Use Loss per common share, diluted ( in dollar per share) Earnings Per Share, Diluted Restricted Stock Restricted Stock [Member] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Expected life (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Events [Abstract] Subsequent Events [Abstract] Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Award term Revenue From Grants, Award Term Revenue From Grants, Award Term Trading Symbol Trading Symbol Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Granted, weighted-average exercise price (in dollar per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Schedule of Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Net loss Net loss Net Income (Loss) Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Liabilities and stockholders' equity Liabilities and Equity [Abstract] Pre Funded Warrant Pre Funded Warrant [Member] Pre Funded Warrant Employees Employees [Member] Employees Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Stockholders' equity: Equity, Attributable to Parent [Abstract] Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Document Fiscal Period Focus Document Fiscal Period Focus Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Share And Accompanying Common Stock Warrants Share And Accompanying Common Stock Warrants [Member] Share And Accompanying Common Stock Warrants Weighted-average exercise price, beginning balance (in dollar per share) Weighted-average exercise price, ending balance (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Proceeds from issuance of equity securities, net Proceeds from Other Equity Equity-based compensation expense Share-Based Payment Arrangement, Noncash Expense BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Common Stock Common Stock [Member] Exercised, weighted-average exercise price (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Equity Components [Axis] Equity Components [Axis] Exercise price (in dollar per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities Shares remaining available for grant of stock awards (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Document Fiscal Year Focus Document Fiscal Year Focus Number of stock options granted (in shares) Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Small Business Entity Small Business Minimum Minimum [Member] Local Phone Number Local Phone Number Receivables [Abstract] Sale of stock, percentage of share In transaction Sale of Stock, Percentage of Share In Transaction Sale of Stock, Percentage of Share In Transaction Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Warrant Warrant [Member] Assets Assets [Abstract] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Aggregate payments under ASCA Payments For Acquisition And Strategic Collaboration Agreement Payments For Acquisition And Strategic Collaboration Agreement Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Series A-1 Warrants Series A-1 Warrants [Member] Series A-1 Warrants Accumulated Deficit Retained Earnings [Member] Total liabilities and stockholders' equity Liabilities and Equity Other assets Other Assets, Noncurrent Ownership [Domain] Ownership [Domain] Loss per common share, basic ( in dollar per share) Earnings Per Share, Basic Unrecognized compensation cost, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Accounting Policies [Abstract] Accounting Policies [Abstract] Workforce reduction percentage Restructuring and Related Cost, Number of Positions Eliminated, Period Percent Sale of Stock [Domain] Sale of Stock [Domain] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Number of shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Warrants and rights outstanding, term Warrants and Rights Outstanding, Term Number of shares called by warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Product and Service [Domain] Product and Service [Domain] Entity Address, City or Town Entity Address, City or Town Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Common stock issued for in-process research and development technology Stock Issued Common stock issued for in-process research and development technology Common stock issued for in-process research and development technology Stock Issued During Period For In-Process Research and Development Technology, Value, New Issues Stock Issued During Period For In-Process Research and Development Technology, Value, New Issues Fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Award Type [Axis] Award Type [Axis] Purchase Agreement Purchase Agreement [Member] Purchase Agreement [Member] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Principles of Consolidation Consolidation, Policy [Policy Text Block] Shares granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Issuance of equity securities for services Stock Issued During Period, Value, Issued for Services Document Transition Report Document Transition Report Outstanding, weighted-average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Accounts payable Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Restricted Stock and Restricted Stock Units Restricted Stock and Restricted Stock Units [Member] Restricted Stock and Restricted Stock Units Entity File Number Entity File Number 2015 Plan Equity Incentive Plan 2015 [Member] Equity Incentive Plan 2015 [Member] Entity Shell Company Entity Shell Company Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Recently Adopted Accounting Standard New Accounting Pronouncements, Policy [Policy Text Block] Title of Individual [Domain] Title of Individual [Domain] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Fair value of awards Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Price per share (in dollar per share) Sale of Stock, Price Per Share Private Placement Private Placement [Member] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Additional paid-in capital Additional Paid in Capital Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock issued for in-process research and development technology (in shares) Stock Issued During Period For In-Process Research and Development Technology, Shares, New Issues Stock Issued During Period For In-Process Research and Development Technology, Shares, New Issues Schedule of Fair Value Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Subsequent Event Type [Axis] Subsequent Event Type [Axis] Series A-2 Warrants Series A-2 Warrants [Member] Series A-2 Warrants Equity-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Proceeds from sale of stock Sale of Stock, Consideration Received on Transaction Grants receivable Increase (Decrease) in Other Receivables Employee Stock Option Employee Stock Option [Member] Forfeited, weighted-average exercise price (in dollar per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Income Taxes Income Tax, Policy [Policy Text Block] Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Unrecognized compensation cost, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Document Type Document Type PREPAID EXPENSES AND OTHER CURRENT ASSETS Other Current Assets [Text Block] Outstanding, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Equity-based compensation expense (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name Subsequent Event [Table] Subsequent Event [Table] EQUITY-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Document Period End Date Document Period End Date Weighted-Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Exercisable, weighted-average exercise price (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Entity Central Index Key Entity Central Index Key Subsequent Event Subsequent Event [Member] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Income Statement [Abstract] Income Statement [Abstract] Issuance of equity securities, net (in shares) Stock Issued During Period, Shares, New Issues Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security FAIR VALUE OF FINANCIAL INSTRUMENTS Fair Value Disclosures [Text Block] Ownership percentage by noncontrolling owner Subsidiary, Ownership Percentage, Noncontrolling Owner In-process research and development technology In-Process Research And Development Technology In-Process Research And Development Technology Issuance of equity securities, net Common stock Shares issued, value Stock Issued During Period, Value, New Issues Equity [Abstract] Equity [Abstract] Other prepaid and current assets Other Assets, Current Equity-based compensation expense Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Class of Stock [Line Items] Class of Stock [Line Items] Grants receivable from CPRIT Grants receivable from CPRIT Grants Receivable, Current Amendment Flag Amendment Flag Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Statistical Measurement [Axis] Statistical Measurement [Axis] Entity Interactive Data Current Entity Interactive Data Current Warrants and rights exercisable, term Warrants and Rights Exercisable, Term Warrants and Rights Exercisable, Term Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Weighted average number of shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Prepaid clinical trial expenses Prepaid Clinical Trial Expense Prepaid Clinical Trial Expense Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Accumulated deficit Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Interest income, net and other Interest Income (Expense), Nonoperating, Net Operating expenses: Operating Expenses [Abstract] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Additional Paid-In Capital Additional Paid-in Capital [Member] Current assets: Assets, Current [Abstract] Expired, weighted-average exercise price (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Total assets Assets Entity Address, State or Province Entity Address, State or Province Cover [Abstract] Warrants Derivatives, Policy [Policy Text Block] Officers and Directors Officers and Directors [Member] Officers and Directors Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities Accrued Expenses And Other Current Liabilities Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] SUBSEQUENT EVENTS Subsequent Events [Text Block] GRANT RECEIVABLE FROM CPRIT Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Class of warrant or right purchase price per warrant or right (in dollar per share) Class Of Warrant Or Right Purchase Price Per Warrant Or Right Class Of Warrant Or Right Purchase Price Per Warrant Or Right Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Grant Grant [Member] Sales Agreement Sales Agreement [Member] Sales Agreement Financial Instruments and Credit Risks Concentration Risk, Credit Risk, Policy [Policy Text Block] Total operating expenses Operating Expenses Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Common stock, par value (in dollar per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Equity Component [Domain] Equity Component [Domain] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Accrued issuance costs for issuance of equity securities Accrued Issuance Costs For Issuance Of Equity Securities Accrued Issuance Costs For Issuance Of Equity Securities Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Loss from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Weighted average number of shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Loss before other income (expense) Operating Income (Loss) University of Utah Research Foundation University of Utah Research Foundation [Member] University of Utah Research Foundation Total liabilities Liabilities ORGANIZATION AND OPERATIONS Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Title of Individual [Axis] Title of Individual [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Statement [Line Items] Statement [Line Items] Plan Name [Axis] Plan Name [Axis] Weighted-Average Remaining Contractual Term (in years) and Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] H.C Wainwright & Co., LLC Warrants H.C Wainwright & Co., LLC Warrants [Member] H.C Wainwright & Co., LLC Warrants Subsequent Event [Line Items] Subsequent Event [Line Items] Common stock, $0.0001 par value; 100,000,000 shares authorized; 3,352,069 and 2,255,899 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Pre-Funded Warrant And Accompanying Common Stock Warrants Pre-Funded Warrant And Accompanying Common Stock Warrants [Member] Pre-Funded Warrant And Accompanying Common Stock Warrants General and administrative General and Administrative Expense Continued payments, percent of net sales Revenue From Grants, Revenue-sharing Payments, Continued Payments, Percent of Net Sales Revenue From Grants, Revenue-sharing Payments, Continued Payments, Percent of Net Sales Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract]